Ozempic maker Novo Nordisk wants the FDA to stop pharmacies from making off-brand versions of popular weight loss meds ...Middle East

Ozempic maker Novo Nordisk (NVO) is asking the U.S. Food and Drug Administration (FDA) to prohibit compounding pharmacies from making off-brand versions of semaglutide, the active ingredient in its blockbuster weight loss and diabetes medications.Read more...

Hence then, the article about ozempic maker novo nordisk wants the fda to stop pharmacies from making off brand versions of popular weight loss meds was published today ( Wednesday 23/10/2024 - 09:05 PM ) and is available on Quartz ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Ozempic maker Novo Nordisk wants the FDA to stop pharmacies from making off-brand versions of popular weight loss meds )

Also on site :

• InCoax strengthens D-series platform for large apartment buildings
• TotalEnergies Raises Dividend as Oil Trading Profits Surge
• What experts say the 1.8m people who need a new mortgage deal this year should do now